Navigating the Grey Zone for Antenatal Corticosteroids

Improving Clinical Practice Guidelines for Antenatal Corticosteroids: Incorporating a Decision Support Tool to Tackle the Uncertain Balance of Harms and Benefits

The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.

Inclusion Criteria:

• Age 18 year or older.
• Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
• Speaks English.
• Agrees to participate in the questionnaire during their first week post-partum.
• Delivered at one of the six participating obstetrical hospitals.

Exclusion Criteria:

• None.